BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Long Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Long Term Provisions | ₹2.56 Cr | ₹2.18 Cr | ₹1.83 Cr | ₹1.48 Cr | ₹1.14 Cr |
What is the latest Long Term Provisions ratio of BETA DRUGS ?
| Year | Long Term Provisions |
|---|---|
| Mar2025 | ₹2.56 Cr |
| Mar2024 | ₹2.18 Cr |
| Mar2023 | ₹1.83 Cr |
| Mar2022 | ₹1.48 Cr |
| Mar2021 | ₹1.14 Cr |
How is Long Term Provisions of BETA DRUGS Trending?
| Years | Long Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹2.56 Cr | 17.35 | |
| Mar2024 | ₹2.18 Cr | 19.14 | |
| Mar2023 | ₹1.83 Cr | 24.00 | |
| Mar2022 | ₹1.48 Cr | 29.84 | |
| Mar2021 | ₹1.14 Cr | - | |
Compare Long Term Provisions of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,329.6 Cr | 1.2% | -7.2% | 13.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,717.0 Cr | -0.8% | -2.5% | 11.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,115.0 Cr | 1.9% | 6.6% | 55.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹189,613.0 Cr | 0.3% | 2% | 35.9% | Stock Analytics | |
| CIPLA | ₹112,876.0 Cr | 0.9% | -0.8% | -10.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,395.0 Cr | 0.1% | 1.4% | -9.3% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1.2% |
-7.2% |
13.9% |
| SENSEX | -0.5% |
-4.8% |
-11% |
You may also like the below Video Courses